Harmony Biosciences Holdings, Inc. HRMY Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $158.69M+9.1% | $145.49M+12.9% | $128.85M-29.0% | $181.47M+425% | ||
| —— | $267K-48.1% | $514K+22.7% | $419K+0.7% | ||
| $44.9M+5.4% | $42.6M+34.4% | $31.71M+21.1% | $26.17M+67.1% | ||
| $348.2M+58.4% | $219.82M+0.2% | $219.39M+51.9% | $144.47M+46.6% | ||
| $310K-73.1% | $1.15M— | —— | $172K-42.3% | ||
| -$39.65M+41.9% | -$68.23M-46.9% | -$46.44M+67.3% | -$141.83M-41.4% | ||
| $16.25M+8.3% | $15M+216% | $4.75M+138% | $2M+300% | ||
| -$9.05M+17.7% | -$11M+89.6% | -$105.55M-1,643% | $6.84M-11.5% | ||
| $299.5M— | —— | —— | —— | ||
| $347.89M+59.1% | $218.67M— | —— | $144.29M+46.9% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does Harmony Biosciences Holdings, Inc.'s cash flow data come from?
- Every line is extracted from Harmony Biosciences Holdings, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.